SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,472.94 -183.15
( -0.24%)

Global Indices

Nasdaq

53,588.00 149.84
(0.28%)

Dow Jones

7,696.83 22.97
(0.30%)

Hang Seng

66,269.23 412.80
(0.63%)

Nikkei 225

10,888.36 2.20
(0.02%)

Forex

USD-INR

95.70 0.06
(0.07%)

EUR-INR

111.67 0.01
(0.01%)

GBP-INR

130.50 0.05
(0.04%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fermenta Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506414

INE225B01021

143.792627

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FERMENTA

23.86

1379.14

EPS(TTM)

Face Value()

Div & Yield %

19.64

0.78

Back

hindustan unilever ltd

Titan Biotech consolidated net profit rises 66.17% in the March 2026 quarter

Jun 02,2026

Net profit of Titan Biotech rose 66.17% to Rs 6.73 crore in the quarter ended March 2026 as against Rs 4.05 crore during the previous quarter ended March 2025. Sales rose 38.84% to Rs 48.83 crore in the quarter ended March 2026 as against Rs 35.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.83% to Rs 29.89 crore in the year ended March 2026 as against Rs 21.53 crore during the previous year ended March 2025. Sales rose 31.79% to Rs 206.19 crore in the year ended March 2026 as against Rs 156.45 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	48.83	35.17	39	206.19	156.45	32
OPM %	19.89	12.99	-	18.72	16.25	-
PBDT	11.58	5.87	97	43.10	28.54	51
PBT	10.28	5.03	104	38.17	24.37	57
NP	6.73	4.05	66	29.89	21.53	39

77,472.94 -183.15 ( -0.24%)

53,588.00 149.84 (0.28%)

7,696.83 22.97 (0.30%)

66,269.23 412.80 (0.63%)

10,888.36 2.20 (0.02%)

95.70 0.06 (0.07%)

111.67 0.01 (0.01%)

130.50 0.05 (0.04%)

0.60 0.00 (0.01%)